Live price temporarily unavailable.
Medpace Holdings (MEDP) is a Health Care company in the Russell 1000. Latest news and coverage below.
| FY2016Dec 2016 | FY2017Dec 2017 | FY2018Dec 2018 | FY2019Dec 2019 | FY2020Dec 2020 | FY2021Dec 2021 | FY2022Dec 2022 | FY2023Dec 2023 | FY2024Dec 2024 | FY2025Dec 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $421.6M | $436.2M | $704.6M | $861.0M | $925.9M | $1.14B | $1.46B | $1.89B | $2.11B | $2.53B |
| Growth (year over year) | +17.4% | +3.5% | +61.5% | +22.2% | +7.5% | +23.4% | +27.8% | +29.2% | +11.8% | +20.0% |
| Operating income | $52.5M | $64.9M | $101.0M | $127.3M | $167.0M | $198.6M | $278.7M | $336.8M | $446.9M | $534.9M |
| Operating margin | 12.5% | 14.9% | 14.3% | 14.8% | 18.0% | 17.4% | 19.1% | 17.9% | 21.2% | 21.1% |
| Net income | $13.4M | $39.1M | $73.2M | $100.4M | $145.4M | $181.8M | $245.4M | $282.8M | $404.4M | $451.1M |
| Net margin | 3.2% | 9.0% | 10.4% | 11.7% | 15.7% | 15.9% | 16.8% | 15.0% | 19.2% | 17.8% |
| EPS (diluted) | $0.37 | $0.98 | $1.97 | $2.67 | $3.84 | $4.81 | $7.28 | $8.88 | $12.63 | $15.28 |
| Balance sheet | ||||||||||
| Cash and equivalents | $37.1M | $26.5M | $23.3M | $131.9M | $277.8M | $461.3M | $28.3M | $245.4M | $669.4M | $497.0M |
| Total assets | $979.1M | $950.7M | $1.00B | $1.14B | $1.39B | $1.66B | $1.35B | $1.66B | $2.10B | $1.98B |
| Total liabilities | $368.4M | $447.2M | $405.9M | $416.8M | $584.9M | $707.0M | $966.1M | $1.10B | $1.28B | $1.52B |
| Long-term debt | $151.3M | $205.1M | $79.7M | $0 | — | — | — | — | — | — |
| Shareholders' equity | $610.7M | $509.3M | $598.9M | $726.3M | $805.8M | $952.9M | $386.4M | $559.0M | $825.5M | $459.1M |
| Cash flow | ||||||||||
| Operating cash flow | $91.7M | $97.4M | $156.6M | $201.9M | $258.7M | $263.3M | $388.1M | $433.4M | $608.8M | $713.2M |
| Capital expenditure | $13.5M | $11.7M | $16.0M | $17.9M | $31.3M | $28.3M | $36.9M | $36.6M | $36.5M | $31.4M |
| Free cash flow | $78.2M | $85.7M | $140.6M | $184.0M | $227.3M | $235.1M | $351.2M | $396.7M | $572.3M | $681.9M |
| Share buybacks | $0 | $155.6M | $0 | $0 | $98.3M | $62.1M | $847.8M | $144.0M | $169.9M | $917.4M |
| Q3 FY24Sep 2024 | Q4 FY24†Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25†Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $533.3M | $536.6M | $558.6M | $603.3M | $659.9M | $708.5M | $706.6M | $707.3M |
| Growth (year over year) | +8.3% | +7.7% | +9.3% | +14.2% | +23.7% | +32.0% | +26.5% | +17.2% |
| Operating income | $112.3M | $125.4M | $113.5M | $126.3M | $141.8M | $153.3M | $141.5M | $146.8M |
| Operating margin | 21.1% | 23.4% | 20.3% | 20.9% | 21.5% | 21.6% | 20.0% | 20.8% |
| Net income | $96.4M | $117.0M | $114.6M | $90.3M | $111.1M | $135.1M | $123.9M | $121.4M |
| Net margin | 18.1% | 21.8% | 20.5% | 15.0% | 16.8% | 19.1% | 17.5% | 17.2% |
| EPS (diluted) | $3.01 | $3.67 | $3.67 | $3.10 | $3.86 | $4.65 | $4.28 | $4.25 |
| Balance sheet | ||||||||
| Cash and equivalents | $656.9M | $669.4M | $441.4M | $46.3M | $285.4M | $497.0M | $652.7M | $502.7M |
| Total assets | $2.08B | $2.10B | $1.90B | $1.57B | $1.75B | $1.98B | $2.13B | $2.06B |
| Total liabilities | $1.20B | $1.28B | $1.30B | $1.40B | $1.46B | $1.52B | $1.53B | $1.62B |
| Shareholders' equity | $881.4M | $825.5M | $593.6M | $172.4M | $293.6M | $459.1M | $598.3M | $433.9M |
| Cash flow | ||||||||
| Operating cash flow | $149.1M | $190.7M | $125.8M | $148.5M | $246.2M | $192.7M | $151.8M | $162.0M |
| Capital expenditure | $10.5M | $7.64M | $9.99M | $6.11M | $10.7M | $4.54M | $6.81M | $23.9M |
| Free cash flow | $138.5M | $183.0M | $115.8M | $142.4M | $235.5M | $188.1M | $145.0M | $138.1M |
| Share buybacks | $0 | $169.9M | $371.9M | $540.9M | $4.57M | $0 | $0 | $294.8M |
From Medpace Holdings's 10-K and 10-Q filings with the SEC; its fiscal year ends in December. Each period shows the latest figure the company has reported for it, including restatements. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →
No recent news mentioning Medpace Holdings in our feed yet.